Anúncios
relacionados a: colorectal cancer guidelinesView Information For Physicians About An FDA-Approved HER2+ mCRC Treatment Option. Frequent Questions For Physicians About Colorectal Cancer. HER2+ mCRC Treatment Option.
HCPs: New Treatment For Metastatic Solid Tumors Including Colorectal Cancer. View Data. Healthcare Professionals: Request A Contact & Access Support Resources For Your Patients.
View Clinical Data for Advanced Colorectal Cancer With the MSI-H Biomarker. Find Resources Here.
Noninvasive Colorectal Cancer Screening For Patients 45+ At Average Risk For CRC. Rx Only. Visit The Healthcare Providers Site To Learn About The Ordering Options For Cologuard®.
Resultado da Busca
8 de ago. de 2020 · Clinical practice guidelines serve as a guide for doctors and outline appropriate methods of treatment and care. Guidelines can address specific clinical situations (disease-oriented) or use of approved medical products, procedures, or tests (modality-oriented).
ESMO has Clinical Practice Guidelines on the following Gastrointestinal Cancers: Rectal Cancer, Biliary cancer, Gastric cancer, Oesophageal cancer, Pancreatic cancer, Metastatic colorectal cancer, Anal cancer, Early colon cancer, Familial risk colorectal cancer, Hepatocellular carcinoma.
2 de mar. de 2021 · This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colorectal cancer (mCRC), because important updates have recently been made to this section.
- Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Mustafa A. Arain, Yi Jen Chen, Kristen K. Ciombo...
- 2021
STATEMENT OF THE PROBLEM. In the United States, an estimated 96,000 and 38,000 new cases of colon and rectal cancer will be diagnosed in 2017.1 Colorectal cancer is the third most common cancer and cause of cancer death in both men and women in the Unit-ed States.
- 195KB
- 19
25 de out. de 2022 · This ESMO Clinical Practice Guideline provides key recommendations for managing metastatic colorectal cancer. •. It covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. •. Treatment algorithms for locoregional, advanced/metastatic and recurrent advanced colorectal cancer are provided. •.
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. H.J. Schmoll. E. Van Cutsem. A. Stein. V. Valentini. B. Glimelius. K. Haustermans. B. Nordlinger. C.J. van de Velde. J. Balmana. J. Regula. I.D. Nagtegaal. R.G. Beets-Tan. D. Arnold. F. Ciardiello. P. Hoff.
